The US Food and Drug Administration on Sunday authorized the use of blood plasma in the treatment of COVID-19, the disease brought on by exposure to the coronavirus.
The US Food and Drug Administration on Sunday authorized the use of blood plasma in the treatment of COVID-19, the disease brought on by exposure to the coronavirus.